Equities

Bioxyne Ltd

Bioxyne Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.014
  • Today's Change0.00 / 0.00%
  • Shares traded6.11m
  • 1 Year change+16.67%
  • Beta1.5315
Data delayed at least 20 minutes, as of Nov 26 2024 05:10 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Tuesday, Bioxyne Ltd (BXN:ASX) closed at 0.014, -33.33% below its 52-week high of 0.021, set on Feb 05, 2024.
52-week range
Today
0.004Jul 10 20240.021Feb 05 2024
Open0.014
High0.015
Low0.014
Bid0.014
Offer0.015
Previous close0.014
Average volume1.51m
Shares outstanding2.05bn
Free float423.68m
P/E (TTM)--
Market cap28.69m AUD
EPS (TTM)-0.0066
AUD
Data delayed at least 20 minutes, as of Nov 26 2024 05:10 GMT.
More ▼

Events & Activity

  • BXN:ASX trading volume exceeds daily average by +27.66%
  • BXN:ASX price moved over +7.69% to 0.014
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.